Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock. Chembio Diagnostics Trading Up 0.2 % CEMI opened at $0.46 on Friday. Chembio Diagnostics has a 12-month low of […]

Related Keywords

,York Mellon Corp ,Vanguard Group Inc ,Renaissance Technologies ,Chembio Diagnostics Inc ,Virtu Financial ,Chembio Diagnostics ,Get Rating ,Advisors Ll Perceptive ,New York Mellon Corp ,Chembio Diagnostics Daily ,Nasdaq Cemi ,Acemi ,Medical ,Initiated Coverage ,Stocknews Com ,